Matrix Trust Co Buys 375 Shares of CME Group Inc. (NASDAQ:CME)

Matrix Trust Co boosted its stake in shares of CME Group Inc. (NASDAQ:CME) by 5.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,729 shares of the financial services provider’s stock after purchasing an additional 375 shares during the quarter. Matrix Trust Co’s holdings in CME Group were worth $1,628,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. OFI Invest Asset Management bought a new position in CME Group during the third quarter worth $25,000. Harbor Investment Advisory LLC boosted its position in shares of CME Group by 966.7% in the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 145 shares during the period. BKM Wealth Management LLC bought a new stake in shares of CME Group in the fourth quarter valued at about $38,000. Compagnie Lombard Odier SCmA bought a new stake in shares of CME Group in the third quarter valued at about $37,000. Finally, Atticus Wealth Management LLC bought a new stake in shares of CME Group in the third quarter valued at about $40,000. 87.75% of the stock is owned by institutional investors.

CME Group Price Performance

CME traded down $1.60 on Friday, hitting $210.94. 1,353,130 shares of the stock were exchanged, compared to its average volume of 1,722,282. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The firm has a market capitalization of $75.94 billion, a price-to-earnings ratio of 24.00, a PEG ratio of 5.92 and a beta of 0.49. CME Group Inc. has a 12 month low of $175.73 and a 12 month high of $223.80. The business has a 50-day moving average of $214.73 and a two-hundred day moving average of $211.90.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.44 by $0.06. The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.42 earnings per share. Sell-side analysts forecast that CME Group Inc. will post 9.67 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were paid a dividend of $1.15 per share. This is an increase from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.18%. CME Group’s payout ratio is presently 52.33%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CME. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $210.00 target price (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Rosenblatt Securities reissued a “sell” rating and issued a $187.00 target price (up previously from $185.00) on shares of CME Group in a research report on Thursday. Barclays boosted their target price on shares of CME Group from $226.00 to $228.00 and gave the company an “equal weight” rating in a research report on Thursday. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $198.00 to $206.00 and gave the company a “neutral” rating in a research report on Thursday. Finally, Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $222.00 to $226.00 and gave the stock a “market perform” rating in a research report on Thursday. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $217.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.